iBio Inc. Shares Close the Day 12.7% Lower - Daily Wrap
The company saw its shares close the day 12.7% lower than yesterday, with trading volume higher than its 30 day average.
Nov 30, 2021 by Kwhen Finance Editors
iBio Inc. (IBIO) shares closed today 12.7% lower than it did at the end of yesterday. The stock is currently down 18.7% year-to-date, down 43.5% over the past 12 months, and down 81.4% over the past five years. Today, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 1.2%.
Trading Activity
- Shares traded as high as $0.98 and as low as $0.56 this week.
- Shares closed 73.7% below its 52-week high and 33.0% above its 52-week low.
- Trading volume this week was 296.5% higher than the 10-day average and 577.6% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.1.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| iBio Inc. | -12.7 | -18.7 | -43.5 | -72.4 | 39.3 |
| Dow Jones Industrial Average | 0.6 | 16.6 | 19.4 | -3.4 | 21.0 |
| S&P 500 Index | 1.2 | 25.5 | 29.6 | -2.0 | 29.6 |
| Health Care | 0.1 | 16.3 | 21.2 | -3.3 | 21.0 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -41.5%
- The company's stock price performance over the past 12 months lags the peer average by 66.6%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| iBio Inc. | IBIO | 0 | -18.7 | -43.5 | -72.4 | 39.3 |
| Peer Avg | N/A | 7.3 | -32.0 | -26.1 | -18.8 | 15.2 |
| Johnson & Johnson | JNJ | 23.5 | 4.1 | 13.7 | -10.3 | 12.1 |
| Emergent Biosolutions Inc | EBS | 10.0 | -53.0 | -49.2 | -65.1 | 48.6 |
| Nektar Therapeutics | NKTR | -4.1 | -34.6 | -33.8 | ||
| Genocea Biosciences Inc | GNCA | 0 | -44.2 | -35.1 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: